Johnson & Johnson (JNJ)
149.12
+1.21
(+0.82%)
USD |
NYSE |
Apr 22, 16:00
149.71
+0.59
(+0.40%)
Pre-Market: 08:48
Johnson & Johnson Total Liabilities (Quarterly): 98.78B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 98.78B |
| September 30, 2023 | 94.83B |
| June 30, 2023 | 115.28B |
| March 31, 2023 | 125.10B |
| December 31, 2022 | 110.57B |
| September 30, 2022 | 100.52B |
| June 30, 2022 | 101.37B |
| March 31, 2022 | 103.65B |
| December 31, 2021 | 108.00B |
| September 30, 2021 | 108.96B |
| June 30, 2021 | 106.86B |
| March 31, 2021 | 106.72B |
| December 31, 2020 | 111.62B |
| September 30, 2020 | 106.22B |
| June 30, 2020 | 95.40B |
| March 31, 2020 | 93.72B |
| December 31, 2019 | 98.26B |
| September 30, 2019 | 97.31B |
| June 30, 2019 | 94.33B |
| March 31, 2019 | 91.07B |
| December 31, 2018 | 93.20B |
| September 30, 2018 | 91.08B |
| June 30, 2018 | 92.48B |
| March 31, 2018 | 93.37B |
| December 31, 2017 | 97.14B |
| Date | Value |
|---|---|
| September 30, 2017 | 81.68B |
| June 30, 2017 | 80.88B |
| March 31, 2017 | 74.58B |
| December 31, 2016 | 70.79B |
| September 30, 2016 | 67.60B |
| June 30, 2016 | 67.34B |
| March 31, 2016 | 63.58B |
| December 31, 2015 | 62.26B |
| September 30, 2015 | 61.71B |
| June 30, 2015 | 60.90B |
| March 31, 2015 | 60.71B |
| December 31, 2014 | 60.61B |
| September 30, 2014 | 55.51B |
| June 30, 2014 | 57.15B |
| March 31, 2014 | 56.75B |
| December 31, 2013 | 58.63B |
| September 30, 2013 | 57.13B |
| June 30, 2013 | 54.66B |
| March 31, 2013 | 54.68B |
| December 31, 2012 | 56.52B |
| September 30, 2012 | 55.19B |
| June 30, 2012 | 55.32B |
| March 31, 2012 | 54.83B |
| December 31, 2011 | 56.56B |
| September 30, 2011 | 50.29B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
93.72B
Minimum
Mar 2020
125.10B
Maximum
Mar 2023
104.08B
Average
103.65B
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 90.92B |
| Gilead Sciences Inc | 39.38B |
| Eli Lilly and Co | 53.14B |
| Merck & Co Inc | 69.04B |
| Shockwave Medical Inc | 897.89M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 167.56B |
| Shareholders Equity (Quarterly) | 68.77B |
| Debt to Equity Ratio | 0.4265 |
| Current Ratio | 1.156 |
| Net Debt Paydown Yield | 2.08% |